Matthew M. Gosling, Senior VP, General Counsel at DEPOMED INC (DEPO), sold 71,000 shares at $15.36 ($1.1M) on 2014-11-19, disclosed to the SEC on 2014-11-21.
Scheduled sale ($1.1M) by Senior VP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DEPO | SELL | 2017-05-15 | $1.3M | — | Filing → |
| DEPO | SELL | 2014-12-03 | $140K | — | Filing → |
| DEPO | SELL | 2014-03-14 | $322K | — | Filing → |